Propofol Suppresses Growth, Migration and Invasion of A549 Cells by Down-regulation of MiR-372

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2018 Dec 15

PMID 30547768

Citations 31

Authors

Hai Sun

Dengyu Gao

Affiliations

Soon will be listed here.

Abstract

Background: Propofol, a commonly used intravenous anesthetic during cancer resection surgery, has been found to exhibit tumor inhibitory effects in vitro and in vivo. The role of propofol in lung cancer has been previously reported, whereas its action mechanism remains unclear. This study further investigated the effects of propofol on lung cancer A549 cell growth, migration and invasion, as well as the underlying mechanisms.

Methods: Cell viability, proliferation, migration, invasion and apoptosis were assessed by CCK-8 assay, BrdU assay, two chamber transwell assay and flow cytometry, respectively. The regulatory effect of propofol on microRNA-372 (miR-372) expression in A549 cells was analyzed by qRT-PCR. Cell transfection was used to change the expression of miR-372. The protein expression of key factors involving in cell proliferation, apoptosis, migration and invasion, as well as Wnt/β-catenin and mTOR pathways were analyzed by western blotting.

Results: Propofol inhibited lung cancer A549 cell viability, proliferation, migration, and invasion, but promoted cell apoptosis. Moreover, miR-372 was down-regulated in propofol-treated A549 cells. Overexpression of miR-372 abrogated the effects of propofol on proliferation, migration, invasion and apoptosis of A549 cells. Knockdown of miR-372 had opposite effects. Furthermore, propofol suppressed Wnt/β-catenin and mTOR signaling pathways by down-regulating miR-372.

Conclusion: Propofol inhibits growth, migration and invasion of lung cancer A549 cells at least in part by down-regulating miR-372 and then inactivating Wnt/β-catenin and mTOR pathways.

Citing Articles

Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathway.

Lin M, Xiao Y, Dai Y, Mao Y, Xu L, Zhang Q Clin Transl Oncol. 2023; 26(4):951-965.

PMID: 37848695 DOI: 10.1007/s12094-023-03328-w.

Optimization of a tri-drug treatment against lung cancer using orthogonal design in preclinical studies.

Tan J, Wang L, Song X, Zhang Y, Song Z, Duan M PeerJ. 2023; 11:e15672.

PMID: 37456863 PMC: 10340110. DOI: 10.7717/peerj.15672.

MicroRNA-372 acts as a double-edged sword in human cancers.

Tajik F, Alian F, Yousefi M, Azadfallah A, Hoseini A, Mohammadi F Heliyon. 2023; 9(5):e15991.

PMID: 37251909 PMC: 10208947. DOI: 10.1016/j.heliyon.2023.e15991.

The effect of propofol on chemosensitivity of paclitaxel in cervical cancer cells.

Jin Y, Xie S, Sheng B, Chen M, Zhu X Cancer Med. 2023; 12(13):14403-14412.

PMID: 37162289 PMC: 10358199. DOI: 10.1002/cam4.6064.

Transcriptome analysis reveals the differential inflammatory effects between propofol and sevoflurane during lung cancer resection: a randomized pilot study.

Wang S, Li M, Cai S, Zhang W World J Surg Oncol. 2023; 21(1):8.

PMID: 36647133 PMC: 9841614. DOI: 10.1186/s12957-023-02891-4.

References

Uematsu K, He B, You L, Xu Z, McCormick F, Jablons D . Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene. 2003; 22(46):7218-21. DOI: 10.1038/sj.onc.1206817. View

Voorhoeve P, le Sage C, Schrier M, Gillis A, Stoop H, Nagel R . A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Adv Exp Med Biol. 2007; 604:17-46. DOI: 10.1007/978-0-387-69116-9_2. View

Hung R, McKay J, Gaborieau V, Boffetta P, Hashibe M, Zaridze D . A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature. 2008; 452(7187):633-7. DOI: 10.1038/nature06885. View

Vasileiou I, Xanthos T, Koudouna E, Perrea D, Klonaris C, Katsargyris A . Propofol: a review of its non-anaesthetic effects. Eur J Pharmacol. 2009; 605(1-3):1-8. DOI: 10.1016/j.ejphar.2009.01.007. View

Cho W, Shin J, Kim J, Lee M, Hong K, Lee J . miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2. Mol Cells. 2009; 28(6):521-7. DOI: 10.1007/s10059-009-0158-0. View

Ish-Shalom S, Lichter A . Analysis of fungal gene expression by Real Time quantitative PCR. Methods Mol Biol. 2010; 638:103-14. DOI: 10.1007/978-1-60761-611-5_7. View

Wiggins J, Ruffino L, Kelnar K, Omotola M, Patrawala L, Brown D . Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res. 2010; 70(14):5923-30. PMC: 2913706. DOI: 10.1158/0008-5472.CAN-10-0655. View

Ellett M . Review of propofol and auxiliary medications used for sedation. Gastroenterol Nurs. 2010; 33(4):284-95. DOI: 10.1097/SGA.0b013e3181eac371. View

Hsing C, Lin M, Choi P, Huang W, Kai J, Tsai C . Anesthetic propofol reduces endotoxic inflammation by inhibiting reactive oxygen species-regulated Akt/IKKβ/NF-κB signaling. PLoS One. 2011; 6(3):e17598. PMC: 3050912. DOI: 10.1371/journal.pone.0017598. View

10.

Zhou A, Diao L, Xu H, Xiao Z, Li J, Zhou H . β-Catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/β-catenin-signaling pathway. Oncogene. 2011; 31(24):2968-78. DOI: 10.1038/onc.2011.461. View

11.

Cui D, Wang L, Qi A, Zhou Q, Zhang X, Jiang W . Propofol prevents autophagic cell death following oxygen and glucose deprivation in PC12 cells and cerebral ischemia-reperfusion injury in rats. PLoS One. 2012; 7(4):e35324. PMC: 3324553. DOI: 10.1371/journal.pone.0035324. View

12.

Yang L, Chen Y, Cui T, Knosel T, Zhang Q, Albring K . Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer. Carcinogenesis. 2012; 33(10):1863-70. DOI: 10.1093/carcin/bgs226. View

13.

Zhang L, Wang N, Zhou S, Ye W, Jing G, Zhang M . Propofol induces proliferation and invasion of gallbladder cancer cells through activation of Nrf2. J Exp Clin Cancer Res. 2012; 31:66. PMC: 3502506. DOI: 10.1186/1756-9966-31-66. View

14.

Wu K, Yang S, Hsia T, Yang J, Chiou S, Lu C . Suppression of cell invasion and migration by propofol are involved in down-regulating matrix metalloproteinase-2 and p38 MAPK signaling in A549 human lung adenocarcinoma epithelial cells. Anticancer Res. 2012; 32(11):4833-42. View

15.

Gu H, Guo X, Zou L, Zhu H, Zhang J . Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma. Mol Cell Biochem. 2013; 375(1-2):23-30. DOI: 10.1007/s11010-012-1521-6. View

16.

Lee H . Exceptional stories of microRNAs. Exp Biol Med (Maywood). 2013; 238(4):339-43. DOI: 10.1258/ebm.2012.012251. View

17.

Forde P, Ettinger D . Targeted therapy for non-small-cell lung cancer: past, present and future. Expert Rev Anticancer Ther. 2013; 13(6):745-58. PMC: 3991462. DOI: 10.1586/era.13.47. View

18.

Nanavaty P, Alvarez M, Alberts W . Lung cancer screening: advantages, controversies, and applications. Cancer Control. 2013; 21(1):9-14. DOI: 10.1177/107327481402100102. View

19.

Cui W, Liu Y, Zhu Y, Song T, Wang Q . Propofol induces endoplasmic reticulum (ER) stress and apoptosis in lung cancer cell H460. Tumour Biol. 2014; 35(6):5213-7. DOI: 10.1007/s13277-014-1677-7. View

20.

Ye Z, Jingzhong L, Yangbo L, Lei C, Jiandong Y . Propofol inhibits proliferation and invasion of osteosarcoma cells by regulation of microRNA-143 expression. Oncol Res. 2014; 21(4):201-7. DOI: 10.3727/096504014X13890370410203. View